A 52-week Study of Remibrutinib in IgE-mediated Food Allergy

ClinicalTrials.gov ID: NCT07768371

Public ClinicalTrials.gov record NCT07768371. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Oct 16, 2026, 10:11 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 52-week Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess Efficacy and Safety of Remibrutinib (LOU064) in Adult and Adolescent Participants With IgE-mediated Food Allergy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this Phase III study is to evaluate the clinical efficacy and safety of remibrutinib in participants with peanut, or cow's milk ("milk", cooked and uncooked) or hen's egg ("egg", cooked and uncooked) immunoglobulin E (IgE)- mediated allergy in comparison to placebo.

Study identification

NCT ID: NCT07768371
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 3
Lead sponsor: Novartis Pharmaceuticals; Industry
Enrollment: 576 participants

Conditions and interventions

Conditions

Interventions

Remibrutinib Drug
Placebo Drug

Drug

Eligibility (public fields only)

Age range: 12 Years to 65 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Aug 27, 2026 (Actual)
Primary completion: Mar 30, 2029 (Estimated)
Completion: Dec 31, 2029 (Estimated)
Last update posted: Oct 13, 2026

2026 – 2029

United States locations

U.S. sites: 18
U.S. states: 15
U.S. cities: 18

Facility	City	State	ZIP	Site status
AllerVie Clinical Research-Homewood	Birmingham	Alabama	35209	Recruiting
Medical Resch of Arizona-Div of Allergy Asthma and Immunology	Scottsdale	Arizona	85251	Recruiting
Arkansas Childrens Hosp Rsch Inst	Little Rock	Arkansas	72202	Recruiting
California Allergy and Asthma Medical Group	Los Angeles	California	90025	Recruiting
Asthma and Allergy Associates P C	Colorado Springs	Colorado	80907	Recruiting
Childrens Healthcare Of Atlanta	Atlanta	Georgia	30329	Recruiting
Sneeze Wheeze Itch Asso LLC	Normal	Illinois	61761	Recruiting
Asthma and Allergy Center of Chicago S C	River Forest	Illinois	60305	Recruiting
Johns Hopkins Hospital	Baltimore	Maryland	21287	Recruiting
Institute for Asthma and Allergy PC	Chevy Chase	Maryland	20815	Recruiting
Childrens Hosp Boston Dept of Heme	Boston	Massachusetts	02115	Recruiting
Respiratory Medicine Research Institute of Michigan	Ypsilanti	Michigan	48197	Recruiting
Impact Medical - Circuit Clinical	Riverdale	New Jersey	07457	Recruiting
Northwell Health	New York	New York	10028	Recruiting
Montefiore Health System	The Bronx	New York	10461	Recruiting
National Allergy and Asthma Research LLS	North Charleston	South Carolina	29420	Recruiting
Western Sky Medical Research	El Paso	Texas	79924	Recruiting
Allergy Associates of Utah	Sandy City	Utah	84093	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT07768371, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Oct 13, 2026 · Synced Oct 16, 2026

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT07768371 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →